Published in Arch Surg on March 01, 1998
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg (2006) 2.03
Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci (2011) 1.71
Current surgical treatment for bile duct cancer. World J Gastroenterol (2007) 1.30
Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol (2005) 1.17
Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol (2007) 1.03
Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol (1999) 1.02
Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg (2009) 1.01
Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol (2010) 0.99
Optimal biliary drainage for inoperable Klatskin's tumor based on Bismuth type. World J Gastroenterol (2007) 0.98
Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) (2009) 0.98
Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol (2012) 0.92
R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int (2010) 0.88
Endoscopic stent placement in the palliation of malignant biliary obstruction. Clin Endosc (2011) 0.85
Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma. World J Gastrointest Endosc (2010) 0.85
Surgical management of proximal bile duct cancers. Langenbecks Arch Surg (2012) 0.83
Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int (2008) 0.83
Evaluation of the effectiveness of endoscopic retrograde cholangiopancreatography in patients with perihilar cholangiocarcinoma and its effect on development of cholangitis. Gastroenterol Res Pract (2014) 0.81
Endoscopic drainage in patients with inoperable hilar cholangiocarcinoma. Korean J Intern Med (2012) 0.80
Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78
Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis. World J Gastroenterol (2017) 0.78
Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review. Can J Gastroenterol Hepatol (2016) 0.78
Sickle cell cholangiopathy: an endoscopic retrograde cholangiopancreatography evaluation. World J Gastroenterol (2009) 0.76
Preoperative biliary MRSA infection in patients undergoing hepatobiliary resection with cholangiojejunostomy: incidence, antibiotic treatment, and surgical outcome. World J Surg (2011) 0.75
ERCP in Patients With Sickle Cell Disease: Diagnostic and Therapeutic Dilemmas. Gastroenterology Res (2010) 0.75
Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med (1993) 5.84
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
A prospective study on fish bone ingestion. Experience of 358 patients. Ann Surg (1990) 3.19
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Tissue-specific expression of a chicken calmodulin pseudogene lacking intervening sequences. Proc Natl Acad Sci U S A (1983) 2.86
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Heterotopic pancreas. Review of a 26 year experience. Am J Surg (1986) 2.61
The ovalbumin gene: alleles created by mutations in the intervening sequences of the natural gene. Cell (1979) 2.56
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
Phylogenetic characterization of novel transport protein families revealed by genome analyses. Biochim Biophys Acta (1999) 2.15
Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg (1997) 2.15
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
Discrete enhancer elements mediate selective responsiveness of enhancer of split complex genes to common transcriptional activators. Dev Biol (1999) 2.07
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
The chick ovomucoid gene contains at least six intervening sequences. Nature (1979) 2.01
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Chicken calmodulin genes. A species comparison of cDNA sequences and isolation of a genomic clone. J Biol Chem (1983) 1.98
Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg (1996) 1.97
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med (1994) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
Assignment of the alpha 1-antitrypsin gene and a sequence-related gene to human chromosome 14 by molecular hybridization. Am J Hum Genet (1983) 1.91
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft. Ann Surg (2000) 1.86
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg (2000) 1.82
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol (1998) 1.80
The natural ovalbumin gene contains seven intervening sequences. Nature (1978) 1.79
Ovalbumin is synthesized in mouse cells transformed with the natural chicken ovalbumin gene. Proc Natl Acad Sci U S A (1980) 1.77
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg (1999) 1.68
Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68
Xenopus neuralized is a ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling. Dev Cell (2001) 1.65
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63
Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg (2003) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
Regulation of Drosophila neurogenesis by RNA:RNA duplexes? Cell (1998) 1.62
Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg (2011) 1.62
The ovalbumin gene: cloning and molecular organization of the entire natural gene. Proc Natl Acad Sci U S A (1979) 1.61
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology (1997) 1.58
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
Proximal bile duct cancer. Quality of survival. Ann Surg (1987) 1.54
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung. J Neuroophthalmol (1998) 1.44
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42
The ovalbumin gene: structural sequences in native chicken DNA are not contiguous. Proc Natl Acad Sci U S A (1978) 1.42
Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J (2005) 1.42
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38
Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36